These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37560740)

  • 1. The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors - a prospective study.
    Tupikowski K; Jaobsche-Policht U; Bittner J; Ptaszkowski K; Halon A; Zdrojowy R; Adamiec R; Gosk-Bierska I
    Arch Med Sci; 2023; 19(4):1003-1010. PubMed ID: 37560740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm.
    Yamazumi K; Ojiro M; Okumura H; Aikou T
    Am J Surg; 1998 Apr; 175(4):297-301. PubMed ID: 9568655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.
    Erem C; Nuhoglu I; Kocak M; Yilmaz M; Sipahi ST; Ucuncu O; Ersoz HO
    Endocrine; 2008 Jun; 33(3):270-6. PubMed ID: 19016004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changing characteristic of blood coagulation factors and their correlation with blood coagulation status in different hepatic diseases].
    Chen J; Duan ZP; Bai L; Zhao J; Ding M; Tong XY; Cong YL
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):206-10. PubMed ID: 22475141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.
    Tóth NK; Csanádi Z; Hajas O; Kiss A; Nagy-Baló E; Kovács KB; Sarkady F; Muszbek L; Bereczky Z; Csiba L; Bagoly Z
    Biomed Res Int; 2017; 2017():3678017. PubMed ID: 28713823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of Hemostasis Disorders in Patients with Critical Limb Ischemia-An In-Depth Comparison of Selected Factors.
    Wieczór R; Kulwas A; Rość D
    J Clin Med; 2020 Feb; 9(3):. PubMed ID: 32121363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study.
    Morange PE; Bickel C; Nicaud V; Schnabel R; Rupprecht HJ; Peetz D; Lackner KJ; Cambien F; Blankenberg S; Tiret L;
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2793-9. PubMed ID: 17023678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive study on hemostasis in CAPD patients treated with erythropoietin.
    Malyszko J; Suchowierska E; Malyszko JS; Mysliwiec M
    Perit Dial Int; 2002; 22(5):582-92. PubMed ID: 12455569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
    Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
    Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.
    Rogolino A; Coccia ME; Fedi S; Gori AM; Cellai AP; Scarselli GF; Prisco D; Abbate R
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):277-82. PubMed ID: 12695751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention].
    Jia XQ; Dong CM; Qin J; Zhang L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):225-8. PubMed ID: 22464576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.
    Erem C; Nuhoglu I; Yilmaz M; Kocak M; Demirel A; Ucuncu O; Onder Ersoz H
    J Endocrinol Invest; 2009 Feb; 32(2):169-74. PubMed ID: 19411818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a 3-Week Low-Calorie Diet and Balneological Treatment on Selected Coagulation Parameters in Morbidly Obese Patients.
    Firszt-Adamczyk A; Ruszkowska-Ciastek B; Adamczyk P; Szafkowski R; Firszt M; Ponikowska I; Moe K; Iwan-Ziętek I; Góralczyk B; Góralczyk K; Rość D
    Adv Clin Exp Med; 2016; 25(4):755-61. PubMed ID: 27629851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant versus amidolytic activity of tissue factor pathway inhibitor in coronary artery disease.
    Mukherjee M; Ranlall N; Patel G; Rutlin A; Jehanli A; Kakkar VV
    Blood Coagul Fibrinolysis; 2000 Apr; 11(3):285-91. PubMed ID: 10870809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Transplantation; 1996 Sep; 62(6):828-30. PubMed ID: 8824484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
    Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
    Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Coagulation and Fibrinolysis Systems During the Perioperative Period of Acute Type A Aortic Dissection.
    Zhou C; Li Y; Yan Y; Feng D; Wei M; Wen J
    Heart Surg Forum; 2021 Mar; 24(2):E223-E230. PubMed ID: 33798057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between hemostatic markers and mortality in COVID-19 - Compounding effects of D-dimer, antithrombin and PAP complex.
    Boknäs N; Laine C; Hillarp A; Macwan AS; Gustafsson KM; Lindahl TL; Holmström M
    Thromb Res; 2022 May; 213():97-104. PubMed ID: 35316719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.